Are these high-risk implants studied on Whites only? Mostly younger white men? Groundbreaking study of high-risk medical devices finds lack of information for patients who are women, people of color, and over 65 years of age.
Read More »Our Medical Journal Articles
Can the FDA Help Reduce Drug Prices or the Cost of Medical Care?
American Journal of Public Health, November, 2017. In a guest editorial by NCHR president Dr. Diana Zuckerman, she questions whether the FDA’s plan to get generic drugs on the market more quickly is enough to make prescription drugs – and health insurance—affordable.
Read More »Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health
The innovation of medical IT has the potential to save lives, but even a small “glitch” can harm patients. Our study found hundreds of recalls of flawed devices that affected millions of patients. Examples include electronic medical records that provide info about the wrong patient and “physician support” devices that miscalculate the dosage of medication. But the FDA is set to deregulate these devices.
Read More »A Major Shortcoming in the Public Health Legacy of the Obama Administration
American Journal of Public Health, December 16, 2016. The Obama Administration has been a strong voice for many public health issues, including tobacco control, childhood obesity, and reproductive health. The Affordable Care Act is also a major accomplishment. But, under the same administration, the FDA caved into political pressure by approving medical products based on lower standards of scientific evidence. What will happen going forward?
Read More »Screening for Lung Cancer: To Be or Not to Be Covered By Medicare?
Journal of Thoracic Imaging, January 2015. Advocates urge Medicare to cover the cost of screening, but the MEDCAC expresses their lack of confidence that the benefits would outweigh the risks.
Read More »